GST on Medical Devices: 5% vs 18% Classification for Hospitals India

An Indian tertiary-care hospital chain closes the September 2026 procurement quarter with 1,842 medical-device invoices booked across its 14 hospitals — 63 capital imaging installations, 217 diagnostic and monitoring devices, 419 orthopaedic implants and cardiac stents, and 1,143 consumable-heavy lines under HSN 3005 and 3006. The finance controller pulls the GST working and finds a familiar exposure item flagged by the internal audit team. 148 of the 1,842 invoices have booked medical devices at 18 percent GST rather than the notified Chapter 90 slab of 5 percent — a total input-side over-invoicing of Rs 1.94 crore for the trailing twelve months, of which the entire amount is permanent cost because the hospital’s healthcare service output under Entry 74 of Notification 12/2017-Central Tax (Rate) is exempt and Section 17(2) read with Rule 43 forces full reversal of the corresponding input tax credit over the 60-month useful life of every capital device. The controller’s next question is the operational one: how do we structure vendor onboarding, purchase-order rate validation, Bill of Entry classification, and Rule 43 reversal so that every rupee of avoidable GST cost is stopped at the PO stage rather than reconciled after the invoice is booked and the ITC clawed back. This is GST medical devices 5 vs 18 percent classification hospital India at operating scale, and getting it right is the single most material controllable-cost lever on the medical-device procurement line.

Quick reference

The reconciliation in one paragraph

The hospital procurement leg carries a compound GST classification exposure that maps to three slabs — 5 percent for HSN 9018 to 9022 medical instruments and apparatus post the 22 September 2025 rate change, 12 percent for HSN 3005 dressings and HSN 3006 sterile surgical kits, and an 18 percent misclassification path for ancillary equipment, IT hardware, plumbing, HVAC and construction inputs that suppliers invoice under general Schedule III headings rather than as parts of a composite medical-apparatus supply under Section 2(30) and Section 8(a) CGST. Every rupee of GST paid on the input side is a permanent cost to the hospital because healthcare service under Entry 74 of Notification 12/2017-CTR is exempt, Section 17(2) restricts input tax credit where inputs are used for exempt supply, and Rule 43 CGST Rules operationalises the restriction on capital goods over a 60-month useful life. For a pure-play hospital with an exempt-turnover ratio of one, the entire capital-goods ITC is clawed back over 60 months — the initial credit to the electronic credit ledger is a mechanical entry that is fully reversed by the terminal month. The reconciliation cascade therefore runs across four surfaces. First, a purchase-order and vendor-invoice validation lattice that enforces the Chapter 90 slab on device lines and the composite-supply rule on ancillary lines. Second, an import lane that validates the Bill of Entry classification against the Chapter 90 slab before IGST is discharged at ICEGATE. Third, a Rule 43 capital-goods reversal workbook per asset that runs the 60-month amortisation and posts monthly Te reversals to GSTR-3B table 4B(1). Fourth, a service-line turnover split that feeds the correct exempt-turnover ratio into the Rule 43 exempt-portion computation. The 5-versus-18 arithmetic on a single Rs 45 lakh MRI machine is a Rs 5.85 lakh permanent-cost leakage that the platform stops at PO release, not at monthly GSTR-3B filing.

What the classification confusion looks like in India

The Indian medical-device procurement channel is a mix of five supply patterns. Domestic OEMs like Trivitron Healthcare, Wipro GE Healthcare (through the GE Healthcare joint venture), Skanray Technologies and Poly Medicure supply directly to hospital chains under HSN 9018 and 9022. Global OEMs like Siemens Healthineers, Philips, GE Healthcare and Canon Medical supply imaging and radiation-therapy apparatus either through Indian subsidiaries invoicing under domestic GST or through direct importation by the hospital under a Bill of Entry. Consumable specialists supply dressings and sterile kits under HSN 3005 and 3006 through distributors. Orthopaedic implant and cardiac-stent specialists supply under HSN 9021, which sat at 5 percent even before the 22 September 2025 rate change under Schedule I item 259 of Notification 1/2017-CTR. Turnkey imaging-suite and cath-lab project vendors bundle apparatus with civil works, plumbing, radiation shielding, HVAC, UPS and IT hardware into composite installations.

The illustrative hospital persona for this article is a tertiary-care chain of 14 hospitals across metros and Tier-2 cities running an approximately Rs 1,250 crore annual procurement programme — approximately Rs 380 crore of medical devices, Rs 210 crore of consumables, Rs 460 crore of drugs and biologicals, and Rs 200 crore of infrastructure and services. Names like Apollo Hospitals, Fortis Healthcare, Max Healthcare, Manipal Hospitals and Narayana Health represent the operating class from which this persona is drawn. The device-procurement leg alone spans hundreds of vendors and thousands of SKUs, and the material classification errors concentrate on three sub-populations. First, imaging-suite ancillaries — UPS systems, PACS workstations, plumbing, shielded-room construction — invoiced by turnkey vendors under HSN 8504, HSN 8471, HSN 7308 or HSN 6810 at 18 percent rather than as parts of a composite HSN 9022 supply at 5 percent. Second, orthopaedic implants invoiced under a generic surgical-supplies HSN at 12 percent rather than the correct HSN 9021 at 5 percent (an error that survived the September 2025 rate change because Schedule I item 259 already covered HSN 9021 at 5 percent from inception). Third, sterile consumables invoiced at 18 percent by suppliers unfamiliar with HSN 3005 and 3006 or by pharmaceutical distributors defaulting to the drug-formulation Schedule III entry. Each error compounds because the hospital cannot claim ITC on the over-charged GST — Section 17(2) read with Rule 43 makes every rupee a permanent cost.

The regulatory overlay — Section 17(2), Rule 43, Entry 74, and the Chapter 90 slab lattice

Four regulatory anchors govern the hospital’s medical-device GST reconciliation, and each maps to a specific control surface.

Notification 1/2017-Central Tax (Rate) dated 28 June 2017 is the primary rate notification. Schedule I lists supplies at 5 percent, Schedule II at 12 percent, Schedule III at 18 percent, and Schedule IV at 28 percent. HSN 9021 orthopaedic appliances sat in Schedule I item 259 from inception. HSN 9018 to 9022 medical instruments and apparatus (other than orthopaedic) sat in Schedule III at 18 percent from 1 July 2017 to 26 July 2018, moved to Schedule II items 218 to 224 at 12 percent from 27 July 2018, and moved to Schedule I at 5 percent from 22 September 2025 following the 56th GST Council rate rationalisation. HSN 3005 (wadding, gauze, bandages, adhesive dressings) and HSN 3006 (pharmaceutical preparations, sterile surgical catgut, first-aid boxes and kits) sat in Schedule II at 12 percent throughout. A hospital’s PO validation therefore has to check both the HSN and the invoice date against the notified schedule position.

Notification 12/2017-Central Tax (Rate) dated 28 June 2017 governs the exemption side. Entry 74 (Heading 9993) exempts services by way of health care by a clinical establishment, an authorised medical practitioner or paramedics. Circular 32/06/2018-GST dated 12 February 2018 clarifies that food supplied to in-patients as part of a composite health-care package is exempt while food supplied to attendants and visitors is taxable at the applicable restaurant-service rate. Notification 3/2022-Central Tax (Rate) dated 13 July 2022, effective 18 July 2022, overlays a 5 percent GST without ITC on room rent (excluding ICU) charged above Rs 5,000 per day per patient. The composite-versus-separately-billed test is decisive for both the output-side exemption and the corresponding input-side ITC treatment.

Section 17(2) of the CGST Act 2017 restricts input tax credit where inputs, input services or capital goods are used partly for taxable and partly for exempt supplies. Rule 42 CGST Rules operationalises the reversal for inputs and input services; Rule 43 operationalises the reversal for capital goods over a 60-month useful life. Monthly reversal Tm equals Tc divided by 60, where Tc is the total ITC on the capital good credited to the electronic credit ledger. Exempt-portion reversal Te equals Tm multiplied by E/F, where E is the aggregate value of exempt supplies during the tax period and F is the total turnover in the State. For a pure-play hospital with E/F approaching 1, the entire capital-goods ITC is reversed over 60 months. The reversal is reported in GSTR-3B table 4B(1). The same Rule 42/43 mechanic applied to a mixed-supply portfolio is walked through in Rule 42 and Rule 43 common credit — when do I apply it.

Section 17(5)(b) of the CGST Act 2017 is a separate blocked-credit list — it disallows ITC on food and beverages, outdoor catering, beauty treatment, health services (as inputs), cosmetic and plastic surgery, and specified rent-a-cab, life and health insurance categories, independent of whether the recipient has any exempt output. A hospital’s staff-canteen catering vendor invoice and staff health-insurance premium sit under Section 17(5)(b); they do not pass through the Rule 43 exempt-turnover computation. The two blocks — Section 17(2) exempt-supply mechanic and Section 17(5)(b) blocked-credit list — operate independently and require separate control surfaces.

The Customs Tariff Act 1975 First Schedule read with Notification 50/2017-Customs governs the import duty stack on medical devices. Basic Customs Duty is typically 7.5 percent on the assessable value under Chapter 90 headings, with concessional or Nil BCD entries for specified life-saving equipment on the Notification 50/2017-Customs concessional list. Social Welfare Surcharge at 10 percent on BCD applies as an additional levy. IGST is discharged on the assessable value plus BCD plus SWS at the domestic Chapter 90 slab (5 percent post 22 September 2025, 12 percent pre-cutover). Correct HSN classification on the Bill of Entry filed at ICEGATE is the primary control — a mis-classification into a general electrical or industrial machinery heading discharges IGST at 18 percent rather than the notified Chapter 90 slab, and the differential is permanent cost after the Rule 43 clawback. For the correct HSN-selection procedure, the how do I find the right HSN code for my product walk-through covers the four-step test.

A worked example — Rs 45 lakh MRI machine and the classification cost lattice

Illustrative — the numbers below are representative of the operating pattern for a tertiary-care hospital chain running a 14-hospital footprint with an approximately Rs 1,250 crore annual procurement programme. Cross-verify against your own vendor price list, Bill of Entry classification and Rule 43 workbook before any operational or filing action.

A tertiary-care hospital’s Radiology Department raises a purchase requisition on 10 September 2026 for a 1.5-Tesla MRI machine with a domestic list price of Rs 45 lakh ex-GST to be sourced from a Wipro GE Healthcare authorised dealer. The device is classifiable under HSN 9018 (magnetic resonance imaging apparatus is expressly listed in the HSN 9018 explanatory notes).

Correct classification — HSN 9018 at 5 percent (post 22 September 2025):

• Device value: Rs 45,00,000
• CGST at 2.5 percent: Rs 1,12,500
• SGST at 2.5 percent: Rs 1,12,500
• Total invoice value: Rs 47,25,000
• ITC credited to electronic credit ledger: Rs 2,25,000
• Rule 43 monthly Tm: Rs 2,25,000 / 60 = Rs 3,750
• E/F for a pure-play hospital: 1.00
• Monthly Te reversal: Rs 3,750
• Cumulative reversal over 60 months: Rs 2,25,000
• Permanent GST cost after Rule 43 clawback: Rs 2,25,000

Misclassified — HSN 8543 (electrical machines with individual functions, not specified elsewhere) at 18 percent:

• Device value: Rs 45,00,000
• CGST at 9 percent: Rs 4,05,000
• SGST at 9 percent: Rs 4,05,000
• Total invoice value: Rs 53,10,000
• ITC credited to electronic credit ledger: Rs 8,10,000
• Rule 43 monthly Tm: Rs 8,10,000 / 60 = Rs 13,500
• Monthly Te reversal: Rs 13,500 (E/F = 1)
• Cumulative reversal over 60 months: Rs 8,10,000
• Permanent GST cost after Rule 43 clawback: Rs 8,10,000

Cost leakage from misclassification: Rs 8,10,000 minus Rs 2,25,000 = Rs 5,85,000 per unit.

Now overlay the import path for the same MRI machine sourced directly from Siemens Healthineers Germany at a CIF value of Rs 3 crore:

Correct classification — HSN 9022 at 5 percent IGST (post 22 September 2025):

• CIF assessable value: Rs 3,00,00,000
• Basic Customs Duty at 7.5 percent: Rs 22,50,000
• Social Welfare Surcharge at 10 percent on BCD: Rs 2,25,000
• Assessable value for IGST: Rs 3,24,75,000
• IGST at 5 percent: Rs 16,23,750
• Total port duties and taxes: Rs 40,98,750
• Landed cost before installation: Rs 3,40,98,750
• ITC on import IGST: Rs 16,23,750
• Rule 43 monthly Tm: Rs 27,062.50
• Cumulative reversal over 60 months (E/F = 1): Rs 16,23,750
• Permanent GST cost after clawback: Rs 16,23,750

Misclassified — HSN 8543 at 18 percent IGST:

• Assessable value for IGST: Rs 3,24,75,000
• IGST at 18 percent: Rs 58,45,500
• Cumulative reversal over 60 months: Rs 58,45,500
• Permanent GST cost after clawback: Rs 58,45,500

Import-side cost leakage from misclassification: Rs 42,21,750 per imported unit.

The Bill of Entry declaration on ICEGATE is therefore the single largest classification control on the import lane — a customs broker or hospital procurement clerk that defaults the HSN into a general electrical-machinery heading burns Rs 42 lakh of avoidable permanent cost per machine, on top of any Rule 43 clawback that would apply to a correctly classified device. Cross-linking the Bill of Entry HSN validation to the Rule 43 asset register is a foundational reconciliation surface for any hospital running an imported-imaging portfolio. The broader hospital-side revenue and receivables reconciliation footprint that intersects with this purchase-side lane is walked through in hospital billing reconciliation India, and the parent rate-transition mechanic that moved HSN 9018-9022 to 5 percent is unpacked in medical devices at 5%: HSN 9018-9022 rate-change reconciliation.

Common reconciliation breakages

Five breakages recur across hospital finance teams navigating the 5-versus-18 classification exposure, and each maps to a specific control failure.

• Composite-supply rule missed on turnkey imaging installations. A cath-lab or MRI-suite turnkey vendor invoices civil works, plumbing, shielded-room construction, UPS and IT hardware under HSN 6810, 7308, 8504 and 8471 at 18 percent alongside the imaging apparatus at 5 percent. Under Section 2(30) read with Section 8(a) CGST, a composite supply is taxed at the rate applicable to the principal supply — here, the imaging apparatus at 5 percent. The hospital’s PO must specify a composite-supply flag on the vendor onboarding record, and every line on the invoice must be pulled into the composite-supply review before the invoice is booked.

• Bill of Entry HSN validated at customs but not against the notified Chapter 90 slab. A customs broker files the Bill of Entry with an HSN drawn from the vendor’s proforma invoice without cross-checking against the Chapter 90 slab notification. IGST is discharged at 18 percent on a machine that is classifiable at 5 percent, and the hospital has no post-clearance remedy short of a Section 26A refund application — which itself requires re-classification concurrence from the assessing officer. The pre-clearance HSN validation is the only reliable control.

• Section 17(2) Rule 43 reversal amortisation started on invoice date rather than installation date. Rule 43 anchors the 60-month useful-life amortisation to the date the capital good is put to use, not the invoice or GRN date. A hospital that starts the Tm reversal from the invoice date on a machine installed six months later has over-reversed for the intervening six months and requires a mid-year correction via GSTR-3B table 4A(5) re-credit and a fresh Tm computation.

• Exempt-turnover ratio E/F set at 1 by default without checking the taxable line contribution. A hospital that runs a taxable pharmacy retail counter, above-Rs-5,000-per-day room-rent revenue (post Notification 3/2022-CTR), a cosmetic surgery vertical or a food-to-attendants-and-visitors line has a non-zero taxable turnover that reduces the E/F ratio and preserves a small residual ITC. Setting E/F = 1 by default over-reverses and understates the surviving credit. The service-line turnover split must be maintained at monthly cadence and fed to the Rule 43 workbook.

• Section 17(5)(b) block-list confused with the Section 17(2) exempt-supply mechanic. Staff canteen catering, staff health insurance and staff motor-vehicle rental sit under the Section 17(5)(b) blocked-credit list and do not pass through the Rule 43 exempt-turnover computation. A hospital that runs these through the Rule 43 workbook double-counts the ineligibility and understates any surviving credit; conversely, one that omits the Section 17(5)(b) block on these lines claims ITC on inputs that are independently blocked, exposing itself to a Section 74 penalty on wrongly availed credit.

How a reconciliation platform handles this

A hospital reconciliation platform ingests the SKU and device master with HSN heading, the vendor and PO master with expected HSN and expected GST rate populated from the SKU master, the vendor-invoice feed with invoiced HSN and invoiced rate, the Bill of Entry feed from ICEGATE with assessable value, BCD, SWS and IGST fields, and the service-line turnover split by exempt healthcare versus taxable pharmacy and above-threshold room rent — and produces a per-device rate-classification reconciliation view that closes the loop from PO release through invoice booking through Rule 43 reversal to GSTR-3B filing. The platform enforces the Chapter 90 slab on device lines, applies the composite-supply rule on turnkey installation invoices, validates every imported-device Bill of Entry against the Chapter 90 slab before IGST discharge, runs the Rule 43 amortisation workbook per capital asset with the correct monthly E/F ratio, and generates the monthly GSTR-3B table 4B(1) reversal line. Match rate improvement from 51 percent to 88 percent on the medical-device rate-classification reconciliation chain, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what makes the platform an infrastructure investment for a tertiary-care hospital chain running hundreds of vendors and thousands of SKUs across the medical-device procurement leg. See GST reconciliation software India for the commercial anchor and reconciliation software India for the umbrella authority.

The five FAQs below address the operational questions Indian hospital finance and procurement teams ask most often on the 5-versus-18 GST classification exposure on medical devices.

Terra Insight Editorial Team Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 9 September 2026

Domain expertise

TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops

Reviewed by

NK

Navin Krishnan

Managing Director & Founder — Terra Insight

Ex Amazon India · Intuit QuickBooks · Tata nexarc

ISO 27001:2022 Patent Pending Incorporated 2024